Table 5 Effect of compound I-1 on body weight and insulin level. Values are presented as Mean ± SEM (no. Of animals, n = 6) and were significantly different at ### p < 0.001 in comparison to normal control group, while *** p < 0.001, **p < 0.01, ns = p > 0.05 when compared with diabetic control group.

From: CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent

Group

Changes in body weight (gm)

Insulin Level (Mean ± SEM) in mg/dl

Before induction

After induction

After treatment

Initial reading

Final reading

Control

193.23 ± 1.24

196.35 ± 1.45

189.35 ± 1.56

0.73 ± 0.12

0.79 ± 0.87

Diabetic

188.86 ± 2.12ns

178.80 ± 1.63###

148.65 ± 2.54###

0.84 ± 0.26ns

0.55 ± 0.13ns

Acarbose

179.98 ± 1.67ns

162.74 ± 2.24**

178.90 ± 4.24***

0.82 ± 0.54ns

0.80 ± 0.18ns

I-1 (10 Mg)

191.23 ± 1.50ns

156.28 ± 3.50***

182.43 ± 4.70***

0.80 ± 0.28ns

0.67 ± 0.25ns

I-1 (20 Mg)

200.23 ± 1.76ns

147.34 ± 1.50ns

188.38 ± 5.67***

0.76 ± 0.48ns

0.75 ± 0.18ns

I-1 (30 Mg)

204.66 ± 3.60***

171.60 ± 1.90ns

198.19 ± 4.66***

0.73 ± 0.38ns

0.70 ± 0.12ns